Inogen | INGN - Current Liabilities


Inogen reported $64.94M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 14.58B 1.14B Sep/2025
AngioDynamics USD 77.97M 10.62M Feb/2025
AtriCure USD 77.84M 9M Sep/2025
Baxter International USD 3.78B 836M Sep/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Boston Scientific USD 5.33B 138M Sep/2025
Chart Industries USD 2.04B 237.4M Sep/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
Dexcom USD 3.34B 27.3M Sep/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Globus Medical USD 465.96M 41.29M Sep/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 647.7M 362.4M Sep/2025
Masimo USD 369.7M 222.4M Sep/2025
Medtronic USD 11.53B 1.35B Jun/2025
Orthofix International USD 159.85M 11.47M Sep/2025
Philips EUR 7.51B 479M Dec/2025
ResMed USD 1.25B 7.39M Dec/2025
Steris USD 922.3M 33.4M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 252.54M 852K Sep/2025
Teleflex USD 773.03M 56.88M Sep/2025
X T L Biopharmaceuticals USD 2.21M 260K Dec/2024
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025